InvisaSkin® Matrix Rebuilder-O

Functions
Anti-aging
Firming
Smoothing
CAS Number(s)
891498-01-4

InvisaSkin® Matrix Rebuilder-O is an anti-aging skin care complex combining the activity of Palmitoyl Hexapeptide-14 (former Palmitoyl Hexapeptide-6 with sequence N-Palmitoyl-L-phenylalanyl-L-alanyl-L-leucyl-L-leucyl-L-lysyl-L-leucinamide) and plant-derived glycoconjugates (Goji berry extract) for a maximum synergistic effect rebuilding skin’s extracellular matrix.

Multiple rebuilding pathways are activated including collagen biosynthesis, fibroblast proliferation, and inhibition of destructive matrix metalloproteinases.  Anti-aging visible results can be seen in the reduction of lines and wrinkles along with a large improvement in skin elasticity.

InvisaSkin® Matrix Rebuilder-O provides enhanced anti-wrinkle and lifting effects by stimulation of fibroblast and collagen synthesis and inhibition of MMP-9. Includes glycoconjugates and a peptide having immunomodulatory functions that boost host gene expression, act as messengers, and induce chemokine production.

InvisaSkin® Matrix Rebuilder-O activates the growth of fibroblast cells and collagen production. Formulated so active components penetrate the epidermis and remain hydrated. Fibroblast messaging continues for up to 24 hours via the delivery package of peptide and glycoconjugate in a hydrated polymer matrix co-formulated with a penetration-enhancing emollient.

Active ingredients (or INCI)

Synonyms
Palmitoyl Hexapeptide-6
F.A.Q.

Is there proof of efficacy for InvisaSkin® Matrix Rebuilder-O?

InvisaSkin® Matrix Rebuilder-O

Increased elastin production firms up skin and helps in recovery from aging, stress, and UV damage.  Skin firmness and resiliency are assessed by cytometry, which measures the elastic response of the skin over time.  A higher degree of elasticity helps lift sags and improve the overall tone of the skin, resulting in a more youthful appearance

Matrix Rebuilder-O exhibits a statistically relevant improvement in elasticity in only four weeks in AMA lab clinical testing.

A twelve-week human panel test of 29 subjects demonstrated that Palmitoyl Hexapeptide-14 is equivalent to RENOVA® (0.05% tretinoin) in reducing the appearance of fine lines and wrinkles with none of the irritation and redness caused by certain retinoid-based products.